Hims & Hers Health announced a definitive agreement to acquire YourBio Health, a pioneer in capillary whole blood sampling technology. The deal includes YourBio’s TAP device, which uses bladeless microneedles for pain-free blood collection. “The next generation of health innovation will be built on proprietary technologies that make wellness simpler, more comfortable, and more human,” said Andrew Dudum, founder and CEO of Hims & Hers. “YourBio’s patented TAP and HALO technologies represent major advancements in user experience and design, and we’re excited to bring them into the Hims & Hers ecosystem.” The transaction is expected to close in early 2026 and is funded entirely with cash from the balance sheet.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Option traders moderately bearish in Hims and Hers Health with shares down 3.13%
- Option traders moderately bearish in Hims and Hers Health with shares down 2.45%
- Moderately bullish activity in Hims and Hers Health with shares up 2.72%
- Mixed options sentiment in Hims and Hers Health with shares up 7.46%
- Mixed options sentiment in Hims and Hers Health with shares down 3.65%